New eye drop hopes to restore feeling to numb corneas

NCT ID NCT07568730

Recruiting now Symptom relief Sponsor: TearSolutions, Inc. Source: ClinicalTrials.gov ↗

First seen May 07, 2026 · Last updated May 20, 2026 · Updated 5 times

Summary

This study tests an eye drop called Lacripep for people with neurotrophic keratitis, a rare eye disease where the cornea loses feeling and doesn't heal properly. About 54 adults with early-stage disease will receive either the active drop or a placebo for 8 weeks. The goal is to see if Lacripep safely improves corneal healing, restores sensitivity, and boosts quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROTROPHIC KERATITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Midwest Cornea Associates
RECRUITING

Carmel, Indiana, 46032, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Minnesota Eye Consultants
RECRUITING

Minneapolis, Minnesota, 55431, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Ophthalmology Associates
NOT_YET_RECRUITING

St Louis, Missouri, 63131, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NEUROTROPHIC KERATITIS